arginyl-glycyl-aspartic acid has been researched along with Uterine Cervical Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hua, L; Li, Y; Liu, H; Tang, G; Wang, C; Xia, Y; Zhong, J; Zhu, B | 1 |
| Hu, Y; Li, N; Li, W; Shen, Y; Sun, D; Tan, J | 1 |
| Curcio, A; K A Silva, A; Lalatonne, Y; Lefèvre, CT; Pignol, D; Plan Sangnier, A; Preveral, S; Wilhelm, C | 1 |
| Huang, TF; Lin, CH; Peng, HC; Sheu, JR | 1 |
4 other study(ies) available for arginyl-glycyl-aspartic acid and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer.
Topics: Apoptosis; Blotting, Western; Cell Migration Inhibition; Cell Proliferation; Female; Gene Silencing; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Membrane Potential, Mitochondrial; Membrane Proteins; Nanoparticles; Oligopeptides; Reactive Oxygen Species; RNA, Small Interfering; Selenium; Tumor Microenvironment; Uterine Cervical Neoplasms | 2020 |
Therapy of cervical cancer using
Topics: Animals; Antineoplastic Agents; Female; HeLa Cells; Humans; Iodine Radioisotopes; Liposomes; Mice; Nanoparticles; Oligopeptides; Tyrosine; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia.
Topics: Animals; Antineoplastic Agents; Female; Genetic Engineering; HeLa Cells; Hot Temperature; Humans; Magnetite Nanoparticles; Magnetosomes; Male; Mice; Mice, Nude; Oligopeptides; PC-3 Cells; Prostatic Neoplasms; Uterine Cervical Neoplasms | 2018 |
Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
Topics: Amino Acid Sequence; Cell Adhesion; Cell Survival; Crotalid Venoms; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Female; Fibronectins; Flow Cytometry; HeLa Cells; Humans; Kinetics; Molecular Sequence Data; Oligopeptides; Peptides; Thymidine; Uterine Cervical Neoplasms | 1994 |